Audiomedica.com
ALK—Targeted Lung Cancer Drugs Benefited Real World Patients
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:00:09
- Mas informaciones
Informações:
Sinopsis
MUNICH— Anaplastic lymphoma kinase (ALK) inhibitors are as effective in “real world” clinical use for treating patients with non-small cell lung cancer (NSCLC) who test positive for ALK gene rearrangements as they are in clinical studies—even though randomized trials “cherry …Mohammad Jahanzeb AJ0
